1154. Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19

MLA

Anil K Gupta, et al. “1154. Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19.” Open Forum Infectious Diseases, vol. 9, Dec. 2022. EBSCOhost, https://doi.org/10.1093/ofid/ofac492.992.

APA

Anil K Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, Moti Ramgopal, Almena Free, Jennifer Han, Jennifer Moore, Rudrani Banerjee, Phillip Yates, Jill Walker, Gretja Schnell, Mary Beth Connolly, Andrea L Cathcart, Varsha Imber, Rabia Anselm, Lindsay Winograd, Nancy Haeusser, Scott Segal, Andrew Skingsley, … Jaynier Moya. (2022). 1154. Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19. Open Forum Infectious Diseases, 9. https://doi.org/10.1093/ofid/ofac492.992

Chicago

Anil K Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, Moti Ramgopal, Almena Free, Jennifer Han, Jennifer Moore, et al. 2022. “1154. Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19.” Open Forum Infectious Diseases 9 (December). doi:10.1093/ofid/ofac492.992.